On June 9, 2025, GE HealthCare Technologies Inc. (ticker: GEHC) announced the issuance of substantial senior notes totaling \(1.5 billion. The company issued \)650 million of 4.8% Senior Notes due January 15, 2031, along with $850 million of 5.5% Senior Notes due June 15, 2035. This move is critical for enhancing the company’s capital structure and supporting its medium to long-term growth objectives.
These notes are senior unsecured obligations, ranking equally with GEHC’s existing senior indebtedness, reflecting the company’s strategic approach to balancing debt levels while maintaining financial flexibility. Interest payments are scheduled semi-annually with the 2031 notes paying interest every January 15 and July 15 starting January 15, 2026, and the 2035 notes every June 15 and December 15 starting December 15, 2025. The maturity dates span from January 2031 through June 2035, underscoring a long-term capital planning horizon.
From a financial impact perspective, as of the fiscal year ended December 31, 2024, GEHC carried \(7.449 billion in long-term debt and total liabilities of \)24.437 billion against revenues of \(19.672 billion. With interest expenses of approximately \)505 million in FY 2024, the added debt service from this new \(1.5 billion issuance at rates of 4.8% and 5.5% will represent an incremental annual interest burden of about \)75 million to $83 million before taxes, a manageable increase that supports the company’s growth financing without undue strain.
This capital raise aligns with sector dynamics in the industrials space, which is capital intensive and sensitive to macroeconomic trends, including infrastructure spending and global economic activity. Strong liquidity and access to capital markets, as demonstrated in this issuance, position GEHC advantageously to capitalize on growing demand for healthcare technologies globally.
In prior earnings calls, GEHC management highlighted their focus on innovation and expanding product offerings to meet rising healthcare needs. The 2025 8-K release sustains this narrative, emphasizing financial strength to back continued investments and operational scalability.
By leveraging this debt issuance, GEHC is not only cementing its financial foundation but also preparing for sustainable growth and competitive positioning in the evolving healthcare technology market.
For full disclosure details, refer to the original SEC filing here: GEHC 8-K SEC Filing.
Tags: GEHC, GEHealthCareTechnologiesInc, FY2024, SeniorNotesIssuance, LongTermDebtManagement, HealthcareTechnologyFunding